Pinnacle Financial Partners Inc. boosted its stake in shares of Humana Inc (NYSE:HUM) by 8.4% in the fourth quarter, Holdings Channel reports. The fund owned 1,161 shares of the insurance provider’s stock after purchasing an additional 90 shares during the period. Pinnacle Financial Partners Inc.’s holdings in Humana were worth $426,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Robeco Institutional Asset Management B.V. lifted its position in Humana by 56.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 40,313 shares of the insurance provider’s stock worth $14,775,000 after acquiring an additional 14,595 shares during the period. Hancock Whitney Corp raised its stake in shares of Humana by 3.1% during the 4th quarter. Hancock Whitney Corp now owns 7,222 shares of the insurance provider’s stock worth $2,647,000 after buying an additional 217 shares in the last quarter. 9258 Wealth Management LLC purchased a new position in shares of Humana during the 4th quarter worth approximately $246,000. Boston Partners raised its stake in shares of Humana by 12.2% during the 4th quarter. Boston Partners now owns 1,537,787 shares of the insurance provider’s stock worth $563,592,000 after buying an additional 167,355 shares in the last quarter. Finally, Signaturefd LLC raised its stake in shares of Humana by 20.7% during the 4th quarter. Signaturefd LLC now owns 677 shares of the insurance provider’s stock worth $248,000 after buying an additional 116 shares in the last quarter. 94.44% of the stock is owned by institutional investors.

NYSE HUM traded down $4.33 during mid-day trading on Friday, hitting $375.87. The stock had a trading volume of 32,319 shares, compared to its average volume of 1,110,214. Humana Inc has a 52-week low of $225.65 and a 52-week high of $381.04. The company has a market cap of $46.75 billion, a price-to-earnings ratio of 18.70, a P/E/G ratio of 1.41 and a beta of 0.95. The company has a 50 day simple moving average of $360.28 and a 200 day simple moving average of $316.11. The company has a quick ratio of 1.83, a current ratio of 1.82 and a debt-to-equity ratio of 0.41.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $2.28 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.08. Humana had a return on equity of 20.89% and a net margin of 4.17%. The firm had revenue of $16.30 billion during the quarter, compared to the consensus estimate of $16.15 billion. During the same period last year, the business posted $2.65 EPS. Humana’s quarterly revenue was up 15.0% on a year-over-year basis. As a group, equities analysts anticipate that Humana Inc will post 18.65 earnings per share for the current fiscal year.

A number of equities analysts have recently issued reports on the company. Wells Fargo & Co reissued an “overweight” rating and set a $400.00 target price (up from $338.00) on shares of Humana in a research note on Wednesday, December 11th. SunTrust Banks reissued a “hold” rating and set a $370.00 target price on shares of Humana in a research note on Tuesday, December 17th. Mizuho increased their target price on Humana from $400.00 to $405.00 and gave the stock a “buy” rating in a research note on Thursday, February 6th. ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Finally, Morgan Stanley increased their target price on Humana from $457.00 to $460.00 and gave the stock an “overweight” rating in a research note on Thursday, February 6th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the stock. Humana presently has a consensus rating of “Buy” and a consensus price target of $380.50.

In related news, Director James J. /Ky Obrien sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $345.21, for a total value of $863,025.00. Also, insider Timothy Alan Wheatley sold 15,019 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $345.21, for a total value of $5,184,708.99. Insiders sold a total of 45,294 shares of company stock valued at $15,894,412 over the last ninety days. 0.54% of the stock is currently owned by company insiders.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: Overbought

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.